Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 12/15/2025 | $1600.00 | Neutral → Buy | BofA Securities |
| 12/9/2025 | $1475.00 | Neutral | Goldman |
| 12/2/2025 | $1550.00 | Equal-Weight | Morgan Stanley |
| 6/24/2025 | $1325.00 | Overweight | Barclays |
| 5/20/2025 | $1350.00 | Neutral → Buy | UBS |
| 5/5/2025 | $1110.00 | Underperform → Hold | Jefferies |
| 5/5/2025 | $1100.00 | Underperform → Hold | Jefferies |
| 4/7/2025 | $1400.00 | Neutral → Buy | Citigroup |
8-K - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Filer)
10-Q - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Filer)
8-K - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Filer)
3 - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Issuer)
4 - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Issuer)
4 - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Issuer)
4 - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Issuer)
BofA Securities upgraded Mettler-Toledo from Neutral to Buy and set a new price target of $1,600.00
Goldman initiated coverage of Mettler-Toledo with a rating of Neutral and set a new price target of $1,475.00
Morgan Stanley initiated coverage of Mettler-Toledo with a rating of Equal-Weight and set a new price target of $1,550.00
Mettler-Toledo International Inc. (NYSE:MTD) announced today that Michael J. Tokich has been appointed to its Board of Directors, effective February 5, 2026. Mr. Tokich served for over 17 years as Senior Vice President and Chief Financial Officer ("CFO") at STERIS plc (NYSE:STE), a leading global healthcare and life science provider of products and services, prior to recently transitioning to the role of Senior Financial Advisor at STERIS. Mr. Tokich joined STERIS in 2000 and held various senior financial roles prior to his appointment as CFO in 2008. Roland Diggelmann, Chair of the Board, stated, "Mike is a highly accomplished executive who brings nearly two decades of U.S. public comp
Mettler-Toledo International Inc. (NYSE:MTD) announced it will release its fourth quarter 2025 financial results after the market close on Thursday, February 5, 2026. The Company will host a conference call the following morning at 8:30 a.m. Eastern Time to discuss the results. To listen to the live audio webcast of the call, visit Events and Presentations on the Investor section of the Company's website, investor.mt.com. METTLER TOLEDO (NYSE:MTD) is a leading global supplier of precision instruments and services. We have strong leadership positions in all of our businesses and believe we hold global number-one market positions in most of them. We are recognized as an innovation leader an
Mettler-Toledo International Inc. (NYSE:MTD) today announced it will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, California on Monday, January 12, 2026 at 4:30 p.m. Pacific Standard Time. A live webcast of the presentation will be available on the Company's investor relations website at investor.mt.com. METTLER TOLEDO (NYSE:MTD) is a leading global supplier of precision instruments and services. We have strong leadership positions in all of our businesses and believe we hold global number-one market positions in most of them. We are recognized as an innovation leader and our solutions are critical in key R&D, quality control, and manufacturing processes
Mettler-Toledo International Inc. (NYSE:MTD) announced it will release its fourth quarter 2025 financial results after the market close on Thursday, February 5, 2026. The Company will host a conference call the following morning at 8:30 a.m. Eastern Time to discuss the results. To listen to the live audio webcast of the call, visit Events and Presentations on the Investor section of the Company's website, investor.mt.com. METTLER TOLEDO (NYSE:MTD) is a leading global supplier of precision instruments and services. We have strong leadership positions in all of our businesses and believe we hold global number-one market positions in most of them. We are recognized as an innovation leader an
Mettler-Toledo International Inc. (NYSE:MTD) today announced third quarter results for 2025. Provided below are the highlights: Reported sales increased 8% compared with the prior year. In local currency, sales increased 6% compared with the prior year. Net earnings per diluted share as reported (EPS) were $10.57, compared with $9.96 in the prior-year period. Adjusted EPS was $11.15, an increase of 9% over the prior-year amount of $10.21. Adjusted EPS is a non-GAAP measure, and a reconciliation to EPS is included on the last page of the attached schedules. Third Quarter Results Patrick Kaltenbach, President and Chief Executive Officer, stated, "Our third quarter results were strong a
Mettler-Toledo International Inc. (NYSE:MTD) announced it will release its third quarter 2025 financial results after the market close on Thursday, November 6, 2025. The Company will host a conference call the following morning at 8:30 a.m. Eastern Time to discuss the results. To listen to the live audio webcast of the call, visit Events and Presentations on the Investor section of the Company's website, investor.mt.com. METTLER TOLEDO (NYSE:MTD) is a leading global supplier of precision instruments and services. We have strong leadership positions in all of our businesses and believe we hold global number-one market positions in most of them. We are recognized as an innovation leader and
Mettler-Toledo International Inc. (NYSE:MTD) announced today that Michael J. Tokich has been appointed to its Board of Directors, effective February 5, 2026. Mr. Tokich served for over 17 years as Senior Vice President and Chief Financial Officer ("CFO") at STERIS plc (NYSE:STE), a leading global healthcare and life science provider of products and services, prior to recently transitioning to the role of Senior Financial Advisor at STERIS. Mr. Tokich joined STERIS in 2000 and held various senior financial roles prior to his appointment as CFO in 2008. Roland Diggelmann, Chair of the Board, stated, "Mike is a highly accomplished executive who brings nearly two decades of U.S. public comp
Appoints Garret Hampton and Alan Sachs to the Board Appoints William Donnelly as Executive Chair of the Board and Jeffrey Elliott as Lead Independent Director Quanterix Corporation ("Quanterix" or the "Company") (NASDAQ:QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced a series of leadership and governance enhancements designed to support the Company's next phase of growth. These changes include the appointment of two highly accomplished life sciences executives, Garret Hampton, Ph.D., and Alan Sachs, M.D., Ph.D., to the Company's Board of Directors, effective immediately. Dr. Hampton most recently served as
Mettler-Toledo International Inc. (NYSE:MTD) announced today that Pablo Perversi has been appointed to its Board of Directors, effective November 6, 2025. Mr. Perversi is the President of Europe at Danone, a leading global food and beverage company, and a member of its Executive Committee. Prior to his current role, Pablo served as Chief Innovation, Quality, and Sustainability Officer and President of Gourmet Division for Barry Callebaut from 2017 to 2022. Before that, he held various roles of increasing responsibility at Unilever from 1993 to 2017, his last position there being Vice President of Foods Europe. Roland Diggelmann, Chair of the Board, stated, "Pablo is a very accomplished
SC 13G/A - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Subject)
SC 13G/A - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Subject)
SC 13G/A - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Subject)